Publication Information

{'id': 'https://openalex.org/W2326446487', 'doi': 'https://doi.org/10.1016/j.juro.2013.02.564', 'title': '982 COMBINED TARGETING OF PI3K/AKT AND AR PATHWAY WITH AZD5363 AND ENZALUTAMIDE INDUCES ANTICANCER ACTIVITY IN PRECLINICAL MODELS OF PROSTATE CANCER', 'display_name': '982 COMBINED TARGETING OF PI3K/AKT AND AR PATHWAY WITH AZD5363 AND ENZALUTAMIDE INDUCES ANTICANCER ACTIVITY IN PRECLINICAL MODELS OF PROSTATE CANCER', 'publication_year': 2013, 'publication_date': '2013-03-27', 'ids': {'openalex': 'https://openalex.org/W2326446487', 'doi': 'https://doi.org/10.1016/j.juro.2013.02.564', 'mag': '2326446487'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/j.juro.2013.02.564', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S30525748', 'display_name': 'The Journal of Urology', 'issn_l': '0022-5347', 'issn': ['0022-5347', '1527-3792'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5010847790', 'display_name': 'Paul Toren', 'orcid': 'https://orcid.org/0000-0002-5762-5787'}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Paul Toren', 'raw_affiliation_strings': ['Vancouver, Canada'], 'affiliations': [{'raw_affiliation_string': 'Vancouver, Canada', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100327316', 'display_name': 'Soojin Kim', 'orcid': 'https://orcid.org/0009-0008-4092-8942'}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Soojin Kim', 'raw_affiliation_strings': ['Vancouver, Canada'], 'affiliations': [{'raw_affiliation_string': 'Vancouver, Canada', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5062125605', 'display_name': 'Martin Gleave', 'orcid': 'https://orcid.org/0000-0003-4235-0167'}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Martin Gleave', 'raw_affiliation_strings': ['Vancouver, Canada'], 'affiliations': [{'raw_affiliation_string': 'Vancouver, Canada', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5081653545', 'display_name': 'Amina Zoubeidi', 'orcid': 'https://orcid.org/0000-0002-0498-142X'}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Amina Zoubeidi', 'raw_affiliation_strings': ['Vancouver, Canada'], 'affiliations': [{'raw_affiliation_string': 'Vancouver, Canada', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.492, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 2, 'citation_normalized_percentile': {'value': 0.625488, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 72, 'max': 76}, 'biblio': {'volume': '189', 'issue': '4S', 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.9988, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.9988, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T13779', 'display_name': 'Cancer Mechanisms and Therapy', 'score': 0.9569, 'subfield': {'id': 'https://openalex.org/subfields/2734', 'display_name': 'Pathology and Forensic Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12465', 'display_name': 'Cancer, Lipids, and Metabolism', 'score': 0.932, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/enzalutamide', 'display_name': 'Enzalutamide', 'score': 0.892897}], 'concepts': [{'id': 'https://openalex.org/C2776551883', 'wikidata': 'https://www.wikidata.org/wiki/Q1996756', 'display_name': 'Enzalutamide', 'level': 5, 'score': 0.892897}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.870427}, {'id': 'https://openalex.org/C75217442', 'wikidata': 'https://www.wikidata.org/wiki/Q423650', 'display_name': 'Protein kinase B', 'level': 3, 'score': 0.7335592}, {'id': 'https://openalex.org/C2780192828', 'wikidata': 'https://www.wikidata.org/wiki/Q181257', 'display_name': 'Prostate cancer', 'level': 3, 'score': 0.70949817}, {'id': 'https://openalex.org/C2779723316', 'wikidata': 'https://www.wikidata.org/wiki/Q6459234', 'display_name': 'LNCaP', 'level': 4, 'score': 0.7031776}, {'id': 'https://openalex.org/C86554907', 'wikidata': 'https://www.wikidata.org/wiki/Q285613', 'display_name': 'PI3K/AKT/mTOR pathway', 'level': 3, 'score': 0.69941324}, {'id': 'https://openalex.org/C61367390', 'wikidata': 'https://www.wikidata.org/wiki/Q416601', 'display_name': 'Androgen receptor', 'level': 4, 'score': 0.5206877}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.48947608}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.4727983}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.36010417}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.32362324}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.31487188}, {'id': 'https://openalex.org/C62478195', 'wikidata': 'https://www.wikidata.org/wiki/Q828130', 'display_name': 'Signal transduction', 'level': 2, 'score': 0.29599667}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.07474342}, {'id': 'https://openalex.org/C95444343', 'wikidata': 'https://www.wikidata.org/wiki/Q7141', 'display_name': 'Cell biology', 'level': 1, 'score': 0.047289193}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/j.juro.2013.02.564', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S30525748', 'display_name': 'The Journal of Urology', 'issn_l': '0022-5347', 'issn': ['0022-5347', '1527-3792'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.61, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4362621709', 'https://openalex.org/W4362609326', 'https://openalex.org/W4362609250', 'https://openalex.org/W4362495275', 'https://openalex.org/W4362495086', 'https://openalex.org/W4361940014', 'https://openalex.org/W4361890616', 'https://openalex.org/W2890810587', 'https://openalex.org/W2767048879', 'https://openalex.org/W2737056430'], 'abstract_inverted_index': {'You': [0], 'have': [1, 117], 'accessJournal': [2], 'of': [3, 143, 162, 168, 177, 198, 298, 354, 374, 380, 392, 400, 411, 424, 433], 'UrologyProstate': [4], 'Cancer:': [5], 'Basic': [6], 'Research': [7], '(V)1': [8], 'Apr': [9], '2013982': [10], 'COMBINED': [11], 'TARGETING': [12], 'OF': [13, 28], 'PI3K/AKT': [14], 'AND': [15, 20, 96], 'AR': [16, 178, 206, 260, 269, 375, 381, 415], 'PATHWAY': [17], 'WITH': [18], 'AZD5363': [19, 203, 335, 371, 418], 'ENZALUTAMIDE': [21], 'INDUCES': [22], 'ANTICANCER': [23], 'ACTIVITY': [24], 'IN': [25], 'PRECLINICAL': [26], 'MODELS': [27], 'PROSTATE': [29], 'CANCER': [30], 'Paul': [31, 40, 474], 'Toren,': [32], 'Soojin': [33, 51, 483], 'Kim,': [34], 'Martin': [35, 62, 492], 'Gleave,': [36], 'and': [37, 73, 139, 155, 165, 204, 219, 249, 257, 268, 277, 294, 309, 317, 336, 339, 346, 378, 387, 414, 419, 426, 428, 452, 470], 'Amina': [38, 74, 501], 'Zoubeidi': [39, 76, 502], 'TorenPaul': [41], 'Toren': [42, 475], 'Vancouver,': [43, 54, 65, 77, 476, 485, 494, 503], 'Canada': [44, 55, 66, 78, 477, 486, 495, 504], 'More': [45, 56, 67, 79, 478, 487, 496, 505], 'articles': [46, 57, 68, 80, 479, 488, 497, 506], 'by': [47, 58, 69, 81, 238, 246, 254, 265, 274, 447, 465, 480, 489, 498, 507], 'this': [48, 59, 70, 82, 481, 490, 499, 508], 'author': [49, 60, 71, 83, 482, 491, 500, 509], ',': [50, 61, 72], 'KimSoojin': [52], 'Kim': [53, 484], 'GleaveMartin': [63], 'Gleave': [64, 493], 'ZoubeidiAmina': [75], 'View': [84], 'All': [85, 511], 'Author': [86], 'Informationhttps://doi.org/10.1016/j.juro.2013.02.564AboutPDF': [87], 'ToolsAdd': [88], 'to': [89, 137, 175, 189], 'favoritesDownload': [90], 'CitationsTrack': [91], 'CitationsPermissionsReprints': [92], 'ShareFacebookTwitterLinked': [93], 'InEmail': [94], 'INTRODUCTION': [95], 'OBJECTIVES': [97], 'Recent': [98], 'advances': [99], 'in': [100, 122, 150, 171, 280, 357, 395, 397, 440, 443], 'castrate': [101], 'resistant': [102, 145, 221], 'prostate': [103, 212, 401], 'cancer': [104, 213, 402], '(CRPC)': [105], 'treatment': [106], 'using': [107, 202, 208, 436], 'androgen': [108], 'receptor': [109], '(AR)': [110], 'targeted': [111], 'therapies': [112], 'such': [113], 'as': [114, 350, 352], 'enzalutamide': [115], '(MDV3100)': [116], 'produced': [118], 'striking': [119], 'survival': [120], 'advantages': [121], 'clinical': [123, 129], 'studies.': [124], 'However,': [125], 'the': [126, 141, 196, 205, 362, 393, 412, 441], 'next': [127], 'major': [128], 'challenge': [130], 'that': [131, 147, 158, 166, 180, 327, 368], 'we': [132, 194, 366], 'will': [133], 'face': [134], 'is': [135, 184, 404], 'how': [136], 'prevent': [138], 'treat': [140], 'emergence': [142], 'MDV3100': [144, 159, 191, 220, 229, 308, 337, 369, 420], 'tumors': [146], 'rapidly': [148], 'occur': [149], 'some': [151], 'CRPC': [152, 312], 'patients.': [153], 'We': [154, 325], 'others': [156], 'found': [157, 326, 367], 'induces': [160], 'phospho-activation': [161], 'AKT': [163, 169, 182, 413], '(pAKT)': [164], 'inhibition': [167], 'results': [170], 'feedback': [172], 'signaling': [173, 270], 'leading': [174], 'activation': [176], 'suggesting': [179], 'inhibiting': [181], 'alone': [183], 'not': [185], 'a': [186, 430], 'good': [187], 'strategy': [188], 'combat': [190], 'resistance.': [192], 'Here': [193], 'investigate': [195], 'effect': [197, 391], 'dual': [199], 'targeting': [200], 'Akt': [201], 'pathway': [207, 271, 416], 'MDV3100.': [209, 233], 'METHODS': [210], 'Human': [211], 'cell': [214, 222, 241, 250, 341, 359], 'lines': [215, 360], 'LNCaP,': [216], 'C4-2,': [217], '22RV1': [218], 'line': [223], '(MR49C)': [224], 'were': [225, 288, 302], 'treated': [226], 'with': [227, 291, 417], 'AZ5363,': [228], 'or': [230], 'AZ5363': [231], 'plus': [232], 'Cell': [234], 'proliferation': [235, 427], 'was': [236, 244, 252, 263, 272, 313, 330], 'assessed': [237, 245, 253, 264, 273], 'crystal': [239], 'violet,': [240], 'cycle': [242], 'population': [243, 356], 'FACS': [247], 'analysis,': [248], 'apoptosis': [251, 342, 425], 'PARP': [255, 344], 'cleavage': [256, 345], 'caspase-3': [258], 'activity.': [259], 'transcriptional': [261, 376], 'activity': [262, 349, 377], 'probasin': [266], 'luciferase': [267], 'western': [275], 'blot': [276], 'qRT-PCR.': [278], 'For': [279], 'vivo': [281, 398], 'anti-cancer': [282], 'activity,': [283], 'male': [284], 'athymic': [285], 'nude': [286], 'mice': [287], 'injected': [289], 's.c.': [290], 'LNCaP': [292], 'cells': [293], 'castrated': [295], 'after': [296], 'start': [297], 'tumor': [299], 'growth.': [300], 'Animals': [301], 'randomly': [303], 'selected': [304], 'for': [305, 435], 'vehicle,': [306], 'AZD5363,': [307], 'AZD5363+MDV3100': [310], 'once': [311], 'identified.': [314], 'Tumor': [315], 'volume': [316], 'serum': [318], 'PSA': [319], 'are': [320], 'being': [321], 'monitored': [322], 'weekly.': [323], 'RESULTS': [324], 'combination': [328, 394], 'therapy': [329], 'more': [331], 'potent': [332], 'than': [333], 'mono-therapy.': [334], 'synergize': [338], 'induce': [340], 'showing': [343], 'caspase': [347], '3': [348], 'well': [351], 'increase': [353], 'subG1/G0': [355], 'all': [358], 'including': [361], 'MDV3100-resistant': [363], 'MR49C.': [364], 'Moreover,': [365], 'abrogates': [370], 'induced': [372], 'up-regulation': [373, 379], 'dependent': [382], 'genes': [383], 'both': [384], 'at': [385], 'mRNA': [386], 'protein': [388], 'levels.': [389], 'The': [390], 'an': [396], 'model': [399], 'progression': [403], 'currently': [405], 'under': [406], 'evaluation.': [407], 'CONCLUSIONS': [408], 'Combined': [409], 'blockade': [410], 'demonstrates': [421], 'significant': [422], 'induction': [423], 'provides': [429], 'preclinical': [431], 'proof': [432], 'principle': [434], 'these': [437], 'two': [438], 'drugs': [439], 'clinic': [442], 'CRPC.': [444], '©': [445], '2013': [446, 464], 'American': [448, 466], 'Urological': [449, 467], 'Association': [450, 468], 'Education': [451, 469], 'Research,': [453, 471], 'Inc.FiguresReferencesRelatedDetails': [454], 'Volume': [455], '189Issue': [456], '4SApril': [457], '2013Page:': [458], 'e403': [459], 'Advertisement': [460, 512, 513], 'Copyright': [461], '&': [462], 'Permissions©': [463], 'Inc.MetricsAuthor': [472], 'Information': [473], 'Expand': [510], 'PDF': [514], 'downloadLoading': [515], '...': [516]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2326446487', 'counts_by_year': [{'year': 2014, 'cited_by_count': 1}, {'year': 2013, 'cited_by_count': 1}], 'updated_date': '2024-12-14T21:17:27.966433', 'created_date': '2016-06-24'}